BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 14579940)

  • 1. Paraoxonase (Pon1) Q192R polymorphism and serum Pon1 activity in diabetic patients on maintenance hemodialysis.
    Zhang B; Eto S; Fan P; Bian C; Shimoji E; Saito T; Saku K
    Clin Nephrol; 2003 Oct; 60(4):257-65. PubMed ID: 14579940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs.
    Sentí M; Tomás M; Marrugat J; Elosua R;
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):415-20. PubMed ID: 11231922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PON1 polymorphisms are predictors of ability to attain HDL-C goals in statin-treated patients.
    de Souza JA; Menin A; Lima LO; Smiderle L; Hutz MH; Van Der Sand CR; Van Der Sand LC; Ferreira ME; Pires RC; Almeida S; Fiegenbaum M
    Clin Biochem; 2015 Nov; 48(16-17):1039-44. PubMed ID: 26079344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Main determinants of PON1 activity in hemodialysis patients.
    Ribeiro S; do Sameiro Faria M; Mascarenhas-Melo F; Freitas I; Mendonça MI; Nascimento H; Rocha-Pereira P; Miranda V; Mendonça D; Quintanilha A; Belo L; Costa E; Reis F; Santos-Silva A
    Am J Nephrol; 2012; 36(4):317-23. PubMed ID: 23007074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association of the Cholesterol Efflux Capacity with the Paraoxonase 1 Q192R Genotype and the Paraoxonase Activity.
    Oniki K; Ohura K; Endo M; Akatwijuka D; Matsumoto E; Nakamura T; Ogata Y; Yoshida M; Harada-Shiba M; Saruwatari J; Ogura M; Imai T
    J Atheroscler Thromb; 2024 Mar; ():. PubMed ID: 38508740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase 1 gene polymorphisms and enzyme activities in diabetes mellitus.
    Flekac M; Skrha J; Žídková K; Lacinová Z; Hilgertová J
    Physiol Res; 2008; 57(5):717-726. PubMed ID: 17949258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Fontana L; Castaldo M; Bonaiuto A; Saitta C; Bitto A; Manduca B; Riggio S; Saitta A
    Exp Gerontol; 2004 Jul; 39(7):1089-94. PubMed ID: 15236768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraoxonase 1 status in the Thai population.
    Phuntuwate W; Suthisisang C; Koanantakul B; Mackness MI; Mackness B
    J Hum Genet; 2005; 50(6):293-300. PubMed ID: 15924216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the role of paraoxonase gene polymorphism (Q192R) and paraoxonase activity in the susceptibility to atherosclerosis among lead-exposed workers.
    Kamal M; Fathy MM; Taher E; Hasan M; Tolba M
    Ann Saudi Med; 2011; 31(5):481-7. PubMed ID: 21911985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of lipid profile with serum PON1 concentration in patients with chronic kidney disease.
    Samouilidou E; Kostopoulos V; Liaouri A; Kioussi E; Vassiliou K; Bountou E; Grapsa E
    Ren Fail; 2016 Nov; 38(10):1601-1606. PubMed ID: 26888625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The paraoxonase promoter polymorphism (-107)T>C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Castaldo M; Fontana L; Bonaiuto A; Bitto A; Saitta C; Saitta A
    Clin Biochem; 2004 May; 37(5):388-94. PubMed ID: 15087255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human serum paraoxonase gene polymorphisms, Q192R and L55M, are not associated with the risk of cerebral infarction in Chinese Han population.
    Huang Q; Liu YH; Yang QD; Xiao B; Ge L; Zhang N; Xia J; Zhang L; Liu ZJ
    Neurol Res; 2006 Jul; 28(5):549-54. PubMed ID: 16808888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of paraoxonase-1(Q192R and L55M) gene polymorphisms and activity with colorectal cancer and effect of surgical intervention.
    Ahmed NS; Shafik NM; Elraheem OA; Abou-Elnoeman SE
    Asian Pac J Cancer Prev; 2015; 16(2):803-9. PubMed ID: 25684529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase 1 (PON1) Q192R genotypes and their interaction with smoking strongly increase atherogenicity and the Framingham risk score.
    Souza-Nogueira A; Camargo AE; Remondi FA; Paoliello MM; Richter RJ; Furlong CE; Barbosa DS; Maes M; Moreira EG
    Arch Endocrinol Metab; 2016 Oct; 60(5):426-435. PubMed ID: 27812605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
    Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
    Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PON1 L55M and Q192R gene polymorphisms and CAD risks in patients with hyperlipidemia : Clinical study of possible associations.
    Chen H; Ding S; Zhou M; Wu X; Liu X; Liu J; Wu Y; Liu D
    Herz; 2018 Nov; 43(7):642-648. PubMed ID: 28835968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity.
    Bortolasci CC; Vargas HO; Souza-Nogueira A; Gastaldello Moreira E; Vargas Nunes SO; Berk M; Dodd S; Barbosa DS; Maes M
    Redox Rep; 2014 Nov; 19(6):232-41. PubMed ID: 25037113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.
    Liberopoulos EN; Papavasiliou E; Miltiadous GA; Cariolou M; Siamopoulos KC; Tselepis AD; Elisaf MS
    Perit Dial Int; 2004; 24(6):580-9. PubMed ID: 15559488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of statin therapy on plasma high-density lipoprotein-cholesterol levels is modified by paraoxonase 1 in Chinese patients with coronary heart disease.
    Fu R; Sun YM; Su Y; Wu Y; Luan Y
    Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):982-3. PubMed ID: 18430057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.